Accounts Payable - InterCure Ltd (NASDAQ:INCR) - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InterCure Ltd
Accounts Payable Peer Comparison

Comparables:
TEVA
RDHL
SLGL
MDWD
R
REKA

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
NASDAQ:INCR
Accounts Payable
â‚Ş133.6m
CAGR 3-Years
93%
CAGR 5-Years
107%
CAGR 10-Years
51%
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Accounts Payable
$2.4B
CAGR 3-Years
15%
CAGR 5-Years
6%
CAGR 10-Years
-2%
Redhill Biopharma Ltd
NASDAQ:RDHL
Accounts Payable
$1.9m
CAGR 3-Years
-59%
CAGR 5-Years
-16%
CAGR 10-Years
-3%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Accounts Payable
$4.8m
CAGR 3-Years
2%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Accounts Payable
$2.7m
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
8%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Accounts Payable
â‚Ş113.9m
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
4%

See Also

What is InterCure Ltd's Accounts Payable?
Accounts Payable
133.6m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Accounts Payable amounts to 133.6m ILS.

What is InterCure Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
51%

Over the last year, the Accounts Payable growth was -23%. The average annual Accounts Payable growth rates for InterCure Ltd have been 93% over the past three years , 107% over the past five years , and 51% over the past ten years .

Back to Top